Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis

Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis

Cannabinoids act as pleiotropic compounds exerting, among others, a broad-spectrum of neuroprotective effects. These effects have been investigated in the last years in different preclinical models of neurodegeneration, with the cannabinoid type-1 (CB<sub>1</sub>) and type-2 (CB<sub&g...

Full description

Bibliographic Details
Main Authors: Sonia Burgaz, Concepción García, Claudia Gonzalo-Consuegra, Marta Gómez-Almería, Francisco Ruiz-Pino, Juan Diego Unciti, María Gómez-Cañas, Juan Alcalde, Paula Morales, Nadine Jagerovic, Carmen Rodríguez-Cueto, Eva de Lago, Eduardo Muñoz, Javier Fernández-Ruiz
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Molecules
Subjects:
cannabinoids
GPR55 receptors
VCE-006.1
chromenopyrazole
Parkinson’s disease
6-hydroxydopamine
Online Access:https://www.mdpi.com/1420-3049/26/24/7643

Internet

https://www.mdpi.com/1420-3049/26/24/7643

Similar Items